Greykasell Wealth Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Hold
381
0.17% 95
2026
Q1
$350K Buy
381
+75
+25% +$76K 0.14% 112
2025
Q4
$329K Hold
306
0.13% 114
2025
Q3
$233K Sell
306
-45
-13% -$33.5K 0.1% 128
2025
Q2
$274K Sell
351
-47
-12% -$36.5K 0.13% 114
2025
Q1
$329K Sell
398
-13
-3% -$10.8K 0.18% 99
2024
Q4
$317K Buy
+411
New +$340K 0.18% 102

Other funds holding LLY

Greykasell Wealth Strategies's LLY Position: Q2 2026 in Review

Greykasell Wealth Strategies held its Eli Lilly (LLY) position steady in Q2 2026 at 381 shares worth $457K. The position accounts for 0.17% of the portfolio, ranked #95.

Greykasell Wealth Strategies first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Greykasell Wealth Strategies held 381 shares of Eli Lilly worth $457K as of Q2 2026.
  • Greykasell Wealth Strategies left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.17% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #95 holding.
  • Greykasell Wealth Strategies first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.